Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1399 clinical trials
Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)

Funding to progress to Phase 2 of this trial has been obtained. It is anticipated 120 subjects participating in Phase 1 will be screened for eligibility for Phase 2 (separate consent and eligibility from Phase 1).

sentinel lymph node biopsy
lumpectomy
invasive breast cancer
mastectomy
lymphedema
  • 0 views
  • 19 Feb, 2024
  • 1 location
NUVOLA TRIAL Open-label Multicentre Study

In a recent phase Ib/II study, olaparib plus weekly carboplatin and paclitaxel in relapsed ovarian cancer patients was shown to be safe, well tolerated and effective, especially in germline BRCA mutated (gBRCAmut) patients. Possibly, the addition of a PARP inhibitor (olaparib) to NACT in HGSOC patient with germline or somatic …

estimated creatinine clearance
liver metastasis
peripheral blood smear
non-melanoma skin cancer
treatment and maintenance
  • 0 views
  • 19 Feb, 2024
  • 1 location
Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag

They will visit NIH every 6 months and repeat the above tests. Participants will be monitored for up to 3 years after they stop taking eltrombopag. They will visit NIH 6 months after treatment ends. If participants blood counts go down after treatment ends, they may restart the drug....

bone marrow biopsy
bone marrow erythroid
blood cell count
eltrombopag
cell counts
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Part 3 and Part 4: Participants aged 6 < 12 will receive risankizumab based on body weight. Around 132 participants will be enrolled in approximately 30 sites worldwide. Risankizumab and ustekinumab are given as a subcutaneous (under the skin) injection.

systemic therapy
pediatric
plaque psoriasis
blood tests
risankizumab
  • 0 views
  • 19 Feb, 2024
  • 9 locations
Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

Due to the lack of evidence for an optimal radiotherapy regimen for an "in-situ vaccination" effect three different radiotherapy regimens will be tested.

neutrophil count
pulmonary function test
large cell carcinoma
measurable disease
pulmonary function tests
  • 0 views
  • 19 Feb, 2024
  • 13 locations
The Effects of Low Dose Ketamine on Cardiovascular Function

Prior studies on low dose ketamine have noted short-term (minutes to hours) increases or decreases in blood pressure. Blood pressure that is too high or too low can be problematic if untreated. It is unknown exactly how low dose ketamine affects blood pressure. In fact, no prior studies have measured …

analgesia
anxiety
systolic blood pressure
body mass index
nervous system
  • 0 views
  • 19 Feb, 2024
  • 1 location
Clinical Feasibility of Minimally Supervised Therapy After Stroke With a Hand Rehabilitation Robot

Minimally supervised therapy means that after a training phase, where the therapists teach to the patients how to perform the exercises with the robot, the patients can autonomously train with the robot during free time without being directly supervised. Our hypothesis is that minimally supervised therapy might be a possible …

ataxia
  • 0 views
  • 19 Feb, 2024
  • 1 location
Effects of Directional Subthalamic Deep Brain Stimulation on Gait and Balance in Parkinson's Disease Patients

Ten patients with Patients with severe form of Parkinson's disease eligible to deep brain stimulation of the subthalamic nucleus, will be included in two French sites.

brain stimulation
estrogen
tubal ligation
dopa
parkinson's disease
  • 0 views
  • 19 Feb, 2024
  • 1 location
Diffusion MRI for Head and Neck Cancer

Previous studies have shown that both diffusion coefficient D and diffusional kurtosis coefficient K are promising imaging markers of (i) cell viability which can be used for evaluation of early treatment response. However, it is often underappreciated that these dMRI metrics are not fixed constants, but rather functions of the …

chemoradiation therapy
chemoradiotherapy
probe
squamous cell carcinoma of head and neck
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Vacuum Assisted Biopsy Immediately Before Surgery as an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer

Vacuum-assisted biopsy (VAB) with the possibility of obtaining tissue of the former tumor center could contribute more reliably to detect any residual tumor or respectively, rule out residual disease. Ultrasound (US) or mammographically (MG) guided VAB will be used in this trial in order to detect residual tumor lesions in …

luminal b breast cancer
primary tumor
remission
residual tumor
adjuvant chemotherapy
  • 0 views
  • 19 Feb, 2024
  • 16 locations